Treatment of transfusional hemosiderosis with deferoxamine may lead to changes in the photoreceptors and retinal pigment epithelium. Here are changes in the pigment content of the cells
Amjad H.S. Rahi, London, GB; European Ophthalmic Pathology Society, 1984.